Buprenorphine Sublingual 72189-0579-60
- Manufacturer
- Direct_rx
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- September 13, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA201760
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Selected Package
72189-0579-60Selected60 TABLET in 1 BOTTLE (72189-579-60)